Close this search box.

LP’s ‘bleeding cash’ while awaiting legalization


Large US MSOs are trading at higher revenue multiples than Canadian LPs: Viridian

Finally, after trending downward for the last year, American MSOs are trading at higher revenue multiples than Canadian LPs, per Viridian Capital’s latest chart of the week.

When President Biden was elected, hopes for federal legalization sent multiples soaring—particularly among Canadian licensed producers (LPs). Now that five of the 10 largest Canadian LPs project negative EBITDA for the next 12 months, that has changed.

“The current constrained financing market has revealed the weakness of the LP strategy: waiting for legalization while bleeding cash,” wrote CFA Frank Colombo, director of data analytics at Viridian. 

Name-checking Canopy Growth, Cronos and Aurora, he wrote, “It is becoming increasingly apparent that some of the formerly robust Canadian LPs may not have the financial capacity to make a sizable US market entrance by the time it is allowed. Some continue to burn so much cash that long-term survivability is in question.”

Enjoy Cannabis Daily each morning at 7 a.m.


Cannabis safety standards vary state-to-state

Without federal oversight, states are implementing different lab-testing standards pertaining to issues like contaminants and potency, writes Bloomberg.

While the methodology and requirements for safety testing every other product sold in the US, from over-the-counter medications to food products, are regulated federally, cannabis is not. 

“Standardization across product forms, product naming, labelling and testing would simplify our business,” said Dennis Curran, CEO of Acreage Holdings.. “But it would be of greatest benefit to consumers, who face a confusing array of products and standards in different states.”


Canada’s latest market share winners and losers: Hifyre

Citing Hifyre’s latest cannabis market share data reported by Cantor, MJBizDaily international editor Matt Lamers tweeted the following update: 

  • HEXO market share declined from 14% to 9.8% since Feb.-April of 2021
  • Organigram rose to 7.9% from 5%
  • Tilray was down from 18% to 7.7% 
  • Canopy was down from 15% to 6.7% 
  • Pure Sunfarms nudged up from 6% to 6.1% 
  • Auxly also increase slightly rom 4% to 5.5% 
  • Decibel rose from 3.2% to 4.2%
  • Cronos also rose from 3.2% to 4.2%
  • And newcomer BZAM earned 3.1% 

Hifyre collects data from four provinces: Ontario, Alberta, Saskatchewan, and BC.

Related Posts

Related Posts


Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you


Browse by Tags




© 2023 Prohibition Holdings Ltd. All Rights Reserved.


Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?